The Effect of DNA Demethylation and IFN‐γ Licensing on HLA‐G Expression in Wharton's Jelly–Derived Mesenchymal Stem Cells
HLA · 2026-06 · 107 (6)
DOI: 10.1111/tan.70799 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, online erschienen am 15.06.2026. Verfasst von Sule Karatas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Graduate Studies in Health Sciences, Istanbul University, Istanbul, Türkiye. Hauptthemen laut MEDLINE: HLA-G Antigens, Interferon-gamma, Mesenchymal Stem Cells, DNA Methylation. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Scientific Research Projects Coordination Unit of Istanbul University.
Abstract (Originalsprache)
Mesenchymal stem cells (MSCs) play a central role in regenerative medicine and immunotherapy owing to their multilineage differentiation capacity and potent immunomodulatory properties. Among MSC sources, Wharton's jelly–derived MSCs (WJ‐MSCs) are particularly attractive due to their non‐invasive procurement, high proliferative potential, and low immunogenicity. Accumulating evidence indicates that human leukocyte antigen G (HLA‐G), a non‐classical major histocompatibility complex (MHC) class I molecule, is a key mediator of MSC‐induced immune tolerance. However, the molecular mechanisms regulating HLA‐G expression in MSCs remain incompletely understood. Epigenetic regulation, particularly DNA methylation within the HLA‐G promoter region, has emerged as a critical determinant of HLA‐G transcriptional activity. In addition, interferon‐gamma (IFN‐γ) is widely recognised as a licensing factor that enhances the immunomodulatory functions of MSCs. In this study, we investigated the effects of DNA demethylation followed by IFN‐γ licensing, applied either sequentially or concurrently, on HLA‐G expression in WJ‐MSCs at early and later culture passages. Our findings demonstrate that DNA demethylation significantly enhances HLA‐G expression in early‐passage WJ‐MSCs, indicating preserved epigenetic plasticity at this stage. In contrast, IFN‐γ licensing did not consistently increase HLA‐G levels unless applied in an epigenetically permissive context. Notably, concurrently applied DNA demethylation and IFN‐γ licensing resulted in elevated HLA‐G protein expression, highlighting the importance of epigenetic priming for effective cytokine responsiveness. In later‐passage WJ‐MSCs, however, responsiveness to both epigenetic modulation and IFN‐γ licensing was reduced and highly variable. Collectively, these results indicate that HLA‐G expression in WJ‐MSCs is regulated by a dynamic interplay between epigenetic status and cytokine licensing, with passage‐dependent epigenetic remodelling critically influencing immunomodulatory capacity. These findings underscore the importance of epigenetic context and passage selection when optimising MSC‐based immunoregulatory strategies for clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Graduate Studies in Health Sciences, Istanbul University, Istanbul, Türkiye.
- Department of Medical Biology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.
- Division of Neonatology, Department of Pediatrics, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.
- Department of Obstetrics and Gynecology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.
- Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.
ORCID-Profile: Sule Karatas
Förderung
- Scientific Research Projects Coordination Unit of Istanbul University
Zitieren
APA
Karatas, S., Suleymanoglu, M., Bozkurt, A. E., Yasa, B., Yasa, C., Ciftci, H. S., Cinar, C. K., Karakas, Z., & Oguz, F. S. (2026). The Effect of DNA Demethylation and IFN‐γ Licensing on HLA‐G Expression in Wharton's Jelly–Derived Mesenchymal Stem Cells. HLA, 107(6). https://doi.org/10.1111/tan.70799
Vancouver
Karatas S, Suleymanoglu M, Bozkurt AE, Yasa B, Yasa C, Ciftci HS, et al. The Effect of DNA Demethylation and IFN‐γ Licensing on HLA‐G Expression in Wharton's Jelly–Derived Mesenchymal Stem Cells. HLA. 2026;107(6). doi:10.1111/tan.70799
BibTeX
@article{Karatas2026,
author = {Karatas, Sule and Suleymanoglu, Mediha and Bozkurt, Ayse Erol and Yasa, Beril and Yasa, Cenk and Ciftci, Hayriye Senturk and Cinar, Cigdem Kekik and Karakas, Zeynep and Oguz, Fatma Savran},
title = {The Effect of DNA Demethylation and IFN‐γ Licensing on HLA‐G Expression in Wharton's Jelly–Derived Mesenchymal Stem Cells},
journal = {HLA},
year = {2026},
volume = {107},
number = {6},
doi = {10.1111/tan.70799}
}
EUVIMED